Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Clinical trial NCT02134067 · TERMINATED
Trial details
- NCT number
- NCT02134067
- Sponsor
- Taiho Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2018-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.